Actual Medicinal Product (AMP) Clipper 5mg gastro-resistant modified-release tablets (Chiesi Ltd)

Stability Information

(Some stability information inherited from generic)

Stability: Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: No stability data in MCAs available but no theoretical concerns with product.
Provenance: This recommendation is based on the product Clipper 5mg gastro-resistant modified-release tablets (Chiesi Ltd).
Generic: Beclometasone
Formulation: Beclometasone 5mg gastro-resistant modified-release tablets

Beclometasone
- Beclometasone 5mg gastro-resistant modified-release tablets
  - Clipper 5mg gastro-resistant modified-release tablets (Chiesi Ltd)